A new study published by Global Medical Genetics reports that cannabidiol may influence drug resistance mechanisms in chronic ...
Receiving a diagnosis of Chronic Myeloid Leukemia (CML) can be frightening, but it is important to understand that the management of this disease is one of the greatest success stories in modern ...
Results from the phase 3 ENDURE trial (NCT03117816), newly published in Leukemia, demonstrate that ropeginterferon alfa-2b ...
Overall, Wall Street has a bullish outlook on the stock with a consensus Strong Buy rating. Terns Pharmaceuticals, Inc.
Two commercialized hematology products, Olverembatinib and Lisaftoclax, drive dual-engine growth with strong China market ...
Enliven Therapeutics jumped on strong ELVN-001 phase 1b CML data, but a rich valuation may cap upside. Click here to read an ...
The leading Chronic Myeloid Leukemia Companies such as Kartos Therapeutics, AOP Orphan Pharmaceuticals, Biokine Therapeutics, ...
Ltd on Monday said it has received tentative approval from the US health regulator for its Bosutinib tablets used in the ...
The pharma business also announced that it has already secured final USFDA approvals for Bosutinib Tablets in the 100 mg and ...
Alembic Pharmaceuticals Ltd has obtained tentative approval from the USFDA for its Bosutinib tablets, used to treat specific ...
Alembic Pharmaceuticals announced that it has received tentative approval from the US Food & Drug Administration (USFDA) for its supplemental Abbreviated New Drug Application (sANDA) for Bosutinib ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback